A Phase 3, Randomized, Open-Label Study of Nivolumab Combined With Cabozantinib Versus Sunitinib in Participants With Previously Untreated Advanced or Metastatic Renal Cell Carcinoma
收藏DataCite Commons2026-04-23 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00013023/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether Nivolumab Combined with Cabozantinib is safe and effective compared to Sunitinib in previously untreated advanced or metastatic renal cell carcinoma
提供机构：
Vivli
创建时间：
2026-04-23
